Stocks and Investing
Stocks and Investing
Mon, March 7, 2022
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Nathan Rich Maintained (ALHC) at Strong Buy with Decreased Target to $16 on, Mar 7th, 2022
Nathan Rich of Goldman Sachs, Maintained "Alignment Healthcare, Inc." (ALHC) at Strong Buy with Decreased Target from $18 to $16 on, Mar 7th, 2022.
Nathan has made no other calls on ALHC in the last 4 months.
There are 5 other peers that have a rating on ALHC. Out of the 5 peers that are also analyzing ALHC, 0 agree with Nathan's Rating of Hold.
These are the ratings of the 5 analyists that currently disagree with Nathan
- Gary Taylor of "Cowen & Co." Maintained at Buy with Decreased Target to $11 on, Friday, March 4th, 2022
- Jeff Garro of "Piper Sandler" Maintained at Buy with Decreased Target to $15 on, Thursday, February 24th, 2022
- John Ransom of "Raymond James" Maintained at Buy with Decreased Target to $20 on, Wednesday, January 12th, 2022
- Lisa Gill of "JP Morgan" Initiated at Buy and Held Target at $20 on, Friday, December 3rd, 2021
- Sarah James of "Barclays" Maintained at Buy with Increased Target to $28 on, Monday, November 8th, 2021
Contributing Sources